Aescap 2.0 Stichting insider trades: Applied Genetic Technologies (AGTC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Aescap reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 26, 2019 | AGTC | ↓ Sell | 81,162 | $5.24 | $425K | Indirect | Dec 30, 2019 (4d) |
| Nov 19, 2019 | AGTC | ↑ Buy | 2,544 | $2.79 | $7K | Indirect | Nov 26, 2019 (7d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Aescap 2.0 Stichting's insider trades
Aescap 2.0 Stichting is a 10% owner of Applied Genetic Technologies (AGTC). Since Nov 19, 2019, Aescap has reported 1 open-market purchase worth $7K and 1 sale worth $425K on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AGTC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.